Edition:
United States

Immunovia AB (publ) (IMMNOV.ST)

IMMNOV.ST on Stockholm Stock Exchange

76.50SEK
15 Dec 2017
Change (% chg)

-4.25kr (-5.26%)
Prev Close
80.75kr
Open
82.25kr
Day's High
82.25kr
Day's Low
75.50kr
Volume
162,584
Avg. Vol
22,980
52-wk High
123.25kr
52-wk Low
75.50kr

Latest Key Developments (Source: Significant Developments)

Immunovia Q3 net loss widens to SEK 11.6 mln‍​
Friday, 10 Nov 2017 02:30am EST 

Nov 10 (Reuters) - IMMUNOVIA AB (PUBL) :NET SALES FOR Q3 2017 WERE SEK 27 THOUSAND (5 K)‍​.THE NET LOSS FOR Q3 2017 WAS SEK 11,589 THOUSAND (-4,048 K)‍​.  Full Article

Immunovia gets SEK 4.9 mln grant from Swelife Accelerator Innovation Program
Monday, 30 Oct 2017 11:41am EDT 

Oct 30 (Reuters) - IMMUNOVIA AB (PUBL) ::IMMUNOVIA RECEIVES SEK4.9 MILLION GRANT FROM SWELIFE ACCELERATOR INNOVATION PROGRAM.  Full Article

Immunovia starts cooperation with ‍Linköping University Medical Faculty ​
Monday, 23 Oct 2017 04:35am EDT 

Oct 23 (Reuters) - IMMUNOVIA AB (PUBL) :STARTS COOPERATION WITH ‍LINKÖPING UNIVERSITY MEDICAL FACULTY ​.  Full Article

Immunovia announces cooperation with Lund University on diabetes research ‍​
Thursday, 7 Sep 2017 09:52am EDT 

Sept 7 (Reuters) - IMMUNOVIA AB (PUBL) ::ANNOUNCES COOPERATION WITH LUND UNIVERSITY ON DIABETES RESEARCH ‍​.  Full Article

Immunovia Q2 operating loss widens to SEK 10.6‍​ million
Wednesday, 23 Aug 2017 02:30am EDT 

Aug 23 (Reuters) - IMMUNOVIA AB (PUBL) :Q2 NET SALES SEK 68,000‍​ VERSUS SEK 66,000 YEAR AGO.Q2 OPERATING LOSS SEK 10.6‍​ MILLION VERSUS LOSS SEK 3.0 MILLION YEAR AGO.  Full Article

Immunovia establishes US headquarters in Boston, Massachusetts
Wednesday, 28 Jun 2017 02:30am EDT 

June 28 (Reuters) - IMMUNOVIA AB (PUBL) :IMMUNOVIA ESTABLISHES US HEADQUARTERS, INCLUDING CLIA REFERENCE LABORATORY, IN BOSTON.‍BOSTON, MASSACHUSETTS USA, HAS BEEN CHOSEN AS LOCATION FOR HEADQUARTERS OF IMMUNOVIA INC, A WHOLLY OWNED SUBSIDIARY.  Full Article

Immunovia biomarker signature for diagnosis of pancreatic cancer patented in Japan
Tuesday, 13 Jun 2017 09:09am EDT 

June 13 (Reuters) - IMMUNOVIA AB (PUBL) ::IMMUNOVIA'S BIOMARKER SIGNATURE FOR DIAGNOSIS OF PANCREATIC CANCER NOW PATENTED IN JAPAN.  Full Article

Immunovia Q1 net loss widens to SEK 7.8 mln
Thursday, 20 Apr 2017 02:46am EDT 

April 20 (Reuters) - IMMUNOVIA AB (PUBL) :Q1 NET SALES SEK 28,000 VERSUS SEK 0 YEAR AGO.Q1 OPERATING EARNINGS LOSS SEK 7.9 MILLION VERSUS LOSS SEK 2.4 MILLION YOY.Q1 NET LOSS SEK 7.8 MILLION VERSUS LOSS SEK 2.4 MILLION YEAR AGO.  Full Article

Immunovia H2 operating loss widens to SEK 9.6 mln
Wednesday, 15 Feb 2017 02:00am EST 

Immunovia AB (publ) : H2 net sales 111 million Swedish crowns ($12.43 million) versus 147 million crowns year ago . H2 operating loss 9.6 million crowns versus loss 3.6 million crowns year ago .Board proposes that no dividend be paid for 2016.  Full Article

Immunovia partners with University of Michigan Pancreatic Cancer Center for PANFAM-1
Monday, 16 Jan 2017 05:45am EST 

Immunovia AB (Publ) : University of Michigan Pancreatic Cancer Center becomes new partner in Immunovia's global PANFAM-1 prospective validation study .Under present agreement, the University of Michigan Pancreatic Cancer Center will contribute together with the other sites to the development of the prospective clinical study that will follow up 1000 high risk study subjects over a period of three years.  Full Article